The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.
Filters
New TB
Democratic People's Republic of Korea
The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.
20192021
Rifampicin test results among TB patients by country in 2021 (new TB)
In 2021, Italy had the highest value (115.6) among 188 countries.
| # | Country | Value | Change |
|---|---|---|---|
| 1 | Italy | 115.6 | -2.4% |
| 1 | Saint Kitts and Nevis (2019) | 100 | 0.0% |
| 1 | American Samoa (2020) | 100 | 0.0% |
| 1 | Wallis and Futuna Islands (2019) | 100 | – |
| 1 | Cayman Islands (2020) | 100 | 0.0% |
| 1 | Iceland (2019) | 100 | +49.9% |
Similar Datasets
The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.
WHO (TB_rdst_num)
Prevalence of bacteriologically-confirmed pulmonary TB who are smear positive among those aged ≥15 years, per 100,000 population
WHO (TB_ps_prev_bc_100k_sp)
Confirmed cases of RR-/MDR-TB
WHO (TB_rr_mdr)
Prevalence of bacteriologically-confirmed pulmonary TB who are smear positive among those aged ≥15 years, per 100,000 population by sex.
WHO (TB_ps_prev_bc_100k_bysex_sp)